Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $75.1300 (2.33%) ($71.4600 - $75.5000) on Thu. Apr. 2, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.32% (three month average) | RSI | 37 | Latest Price | $75.1300(2.33%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV advances 0.4% a day on average for past five trading days. | Weekly Trend | ABBV advances 0.3% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(56%) SPLV(44%) VYM(42%) DIA(41%) IVE(40%) | Factors Impacting ABBV price | ABBV will decline at least -1.66% in a week (0% probabilities). VIXM(-30%) UUP(-11%) VXX(-9%) TLT(-6%) UNG(3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.66% (StdDev 3.32%) | Hourly BBV | 0.3 () | Intraday Trend | 3.2% | | | |
|
Inflection Point | Yes | Resistance Level | $75.47 | 5 Day Moving Average | $74.53(0.81%) | 10 Day Moving Average | $71.72(4.75%) | 20 Day Moving Average | $75.47(-0.45%) | To recent high | -23.2% | To recent low | 16.5% | Market Cap | $132.551b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |